Financings – Cont. from Vital Signs 11/14/23
more info
We had several financings that didnt make the 11/14 edition of Vital Signs.

VectorY Therapeutics – a biotech company developing antibody therapies to treat neurodegenerative diseases, raised a $138M Series A. (Amsterdam, Netherlands)

Needed – a company that develops nutrition products for prenatal care, raised $14M. (LA, CA)

Recent Posts

In Memory of Charlie Emley, Jr.

Approximately 35 years ago I was visiting the home of my college buddy in Pasadena,…

Is The Venture Capital Party Over?

Mark Twain famously said “The reports of my death are greatly exaggerated.” Such is the…

Ai Juggernaut Palantir Enters Healthcare

Palantir is not exactly a household name, but the Peter Thiel founded company now based…